This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
NUCYNTA EXTENDED-RELEASE
ENDO VENTURES LTD
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of NUCYNTA EXTENDED-RELEASE in Canada?
Yes. NUCYNTA EXTENDED-RELEASE 250MG has an active shortage reported to Health Canada (last updated October 27, 2026).
Why is NUCYNTA EXTENDED-RELEASE not available?
The reason the manufacturer reported: Delay in shipping of the drug.
When will NUCYNTA EXTENDED-RELEASE be available again?
The estimated resolution date (November 11, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02415615
Strength
250MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Active Ingredient
Tapentadol
Tier
Unrated
Last Updated
2017-12-06
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
NUCYNTA EXTENDED-RELEASE has 2 shortage/discontinuation reports on file — this is one of them.